BiotechTube
Home/ReGelTec/Dr. Anthony Lowman
DA

Dr. Anthony Lowman

CTO & Co-Founder

ReGelTec

Therapeutic Areas

MusculoskeletalPain

ReGelTec Pipeline

DrugIndicationPhase
HYDRAFIL SystemChronic low back pain due to degenerative disc disease (DDD)Pivotal Trial (IDE)

Leadership Team at ReGelTec

PB
Peter Boyd, JD, MBA
CEO
MC
Mark Collins, CPA
CFO
View full ReGelTec profile